NEU 1.07% $14.20 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-91

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    Shame that the kids on the trial can’t stay on the medication after experiencing those improvements. That would be hard for them and their families
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.